UPC_APP_24411/2025

System for ambulatory drug infusion comprising a filling apparatus for flexible containers

Procedural & sub-applicationsSettlement HomologationCourt of AppealApplication Rop 365—Settled at: Post-appeal

Overview Decisions Citations Documents Timeline

Parties

Claimants

Tandem Diabetes Care Europe B.V.
Tandem Diabetes Care, Inc.

Reps: Christian Dekoninck (Taylor Wessing); null (AOMB)

Respondents

Roche Diabetes Care GmbH(Roche Group)

Reps: Christof Augenstein (Kather Augenstein); null (Grünecker Patent- und Rechtsanwälte)

Judges

Rian KaldenPresiding judge and legally qualified judge
Ingeborg SimonssonLegally qualified judge and judge-rapporteur
Patricia RombachLegally qualified judge
Jeroen MeewisseTechnically qualified judge
Stefan WilhelmTechnically qualified judge

Patents

EP2196231

CPC codes: A61M2209/045, A61M5/148, A61M5/14244

Sector: Pharmaceutical & Medical

Outcome

Settled

Filed: —

First decided: Jun 5, 2025

Language: —

Settled at: Post-appeal — settled commercially

The Court of Appeal confirmed a settlement agreement between Tandem Diabetes and Roche Diabetes, terminating the appeal proceedings. The settlement arose after the Central Division Paris had dismissed the revocation action and maintained EP 2 196 231 as granted.